Author Topic: The funds just aren't there when it comes to looking for SPMS treatments  (Read 77 times)

0 Members and 2 Guests are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9821
  • MS diagnosed 1980
  • Location: Pacific Northwest
A release from the AAAS (via EurekAlert.org), August 20, 2019--"How to Improve Multiple Sclerosis Therapy":


https://www.eurekalert.org/pub_releases/2019-08/rb-hti082019.php


This part in particular:


There are also financial aspects that impede the development of new drugs. There is evidence that drugs approved for another indication may also prove effective against multiple sclerosis. "But as patents for such medication have expired, pharmaceutical companies can't further develop them," explains Simon Faissner [of the Department of Neurology, Ruhr University-Bochum]. "The implementation of studies to test the efficacy of those drugs for MS often fails due to a lack of funds."
« Last Edit: August 23, 2019, 04:37:14 pm by agate »
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20.

Offline agate

  • Administrator
  • *****
  • Posts: 9821
  • MS diagnosed 1980
  • Location: Pacific Northwest
More on this study in Multiple Sclerosis News Today (August 22, 2019)--"Lack of progressive MS treatments has several causes, but advances are promising, reviewers contend":


http://bit.ly/33YRZlk
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20.

 

Related Topics

  Subject / Started by Replies Last post
0 Replies
88 Views
Last post October 17, 2016, 03:33:01 pm
by agate
0 Replies
80 Views
Last post April 20, 2018, 01:54:36 pm
by agate
0 Replies
131 Views
Last post July 26, 2018, 05:39:51 am
by agate
0 Replies
30 Views
Last post June 05, 2020, 08:09:00 pm
by agate
0 Replies
21 Views
Last post April 23, 2022, 09:33:20 pm
by agate